Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Pharmaceutical Patent Protection and World Trade Law : The Unresolved Problem of Access to Medicines, Hardback Book

Pharmaceutical Patent Protection and World Trade Law : The Unresolved Problem of Access to Medicines Hardback

Part of the Routledge Research in Intellectual Property series

Hardback

Description

Patents, including pharmaceutical patents, enjoy extended protection for twenty years under the TRIPs Agreement.

The Agreement has resulted in creating a two-tier system of the World Trade Organisation Member States, and its implementation has seen the price of pharmaceutical products skyrocket, putting essential medicines beyond the reach of the common man.

The hardest hit populations come from the developing and least developed countries, which have either a weak healthcare system or no healthcare at all, where access to essential and affordable medicines is extremely difficult to achieve. Pharmaceutical Patent Protection and World Trade Law studies the problems faced by these countries in obtaining access to affordable medicines for their citizens in light of the TRIPS Agreement.

It explores the opportunities that are still open for some developing countries to utilise the flexibilities available under the TRIPS Agreement in order to mitigate the damage caused by it.

The book also examines the interrelationship between the world governing bodies, and the right to health contained in some of the developing country’s national constitutions.

Information

Other Formats

£135.00

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Routledge Research in Intellectual Property series  |  View all